Tech Company Financing Transactions
Trobix Bio Funding Round
Trobix Bio closed a $3 million financing round on 3/30/2023. Backers included Chartered Group.
Transaction Overview
Company Name
Announced On
3/30/2023
Transaction Type
Venture Equity
Amount
$3,000,000
Round
Undisclosed
Investors
Chartered Group (Lead Investor)
Proceeds Purpose
The company intends to use the funds for the development of its products and proprietary platform technology, which addresses the gastrointestinal side effects of oncology treatments and other gastrointestinal diseases impacted by the microbiome.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
45 Ha'Melacha Street
Netanya, 4250574
IL
Netanya, 4250574
IL
Phone
Undisclosed
Website
Email Address
Overview
Founded on groundbreaking technology to game change the fight against antimicrobial resistance, Trobix Bio is expanding its vision to empower engineered phages with CRISPR to develop precision microbiome-based therapeutics that address huge unmet needs in major medical therapeutic areas
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Adi Elkeles
Chief Financial Officer
Chanan Morris
Browse more venture capital transactions:
Prev: 3/30/2023: SEO venture capital transaction
Next: 3/30/2023: Dashbot venture capital transaction
Share this article
About Database of VC Transactions
We report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs